{"screen_name":{"0":"NEJM","1":"NEJM","2":"NEJM"},"tweet_id":{"0":1335365837759266816,"1":1335358287865393152,"2":1335252591324909570},"is_retweet":{"0":false,"1":false,"2":false},"text":{"0":"In patients with sickle cell disease, the genetic silencing of BCL11A resulted in increased expression of\u00a0fetal hemoglobin\u00a0and a decline in the frequency of sickle cell crises. #ASH20","1":"Two patients, one with transfusion-dependent \u03b2-thalassemia and one with sickle cell disease, received autologous CD34+ cells edited with CRISPR-Cas9 targeting of BCL11A. Their clinical course supports further experimental testing of gene editing to treat these diseases.\u00a0#ASH20","2":"Covid-19 Rx: Your task is to gather data, develop a differential diagnosis, order additional diagnostic tests, and treat the patient. (Optimized for desktop PCs and most tablets.) \n@NEJMGroup #COVID19"},"user_verified":{"0":true,"1":true,"2":true},"created_at":{"0":"2020-12-05 23:30:00","1":"2020-12-05 23:00:00","2":"2020-12-05 16:00:00"},"retweet_count":{"0":59,"1":100,"2":39},"favorite_count":{"0":230,"1":323,"2":130},"user_location":{"0":"Boston, MA","1":"Boston, MA","2":"Boston, MA"},"user_url":{"0":"http:\/\/t.co\/MskhpINH4c","1":"http:\/\/t.co\/MskhpINH4c","2":"http:\/\/t.co\/MskhpINH4c"},"entities":{"0":{"hashtags":[{"text":"ASH20","indices":[177,183]}],"symbols":[],"user_mentions":[],"urls":[]},"1":{"hashtags":[{"text":"ASH20","indices":[271,277]}],"symbols":[],"user_mentions":[],"urls":[]},"2":{"hashtags":[{"text":"COVID19","indices":[192,200]}],"symbols":[],"user_mentions":[{"screen_name":"NEJMGroup","name":"NEJM Group","id":437804849,"id_str":"437804849","indices":[181,191]}],"urls":[]}}}